FairValueLabs Valuation System Value Investment
CPB

The Campbell's Company (CPB) Stock Analysis — Fair Value, Risk & Moat Rating

NMS · Consumer Defensive · Packaged Foods

$20.82 Watch Zone -0.09 (-0.4%) As of Apr 22, 2026 Not a buy/sell recommendation. See disclaimer.
Overall Verdict Caution
1.67
Altman Z-ScoreDistress Zone
$20.83
Fair ValueWatch Zone (0.1%)
3.4
Moat RatingNarrow moat
TL;DR · Audit Summary

Is The Campbell's Company a safe investment right now?

The Campbell's Company's Altman Z-Score of 1.67 places it in the distress zone. Our fair value estimate is $20.83 (Watch Zone). Moat rating: 3.4/5 stars.

Price Chart · CPB
Section 01 · Financial Health

Could The Campbell's Company go bankrupt? Altman Z-Score analysis

1.67

Z-Score of 1.67 falls below the 1.8 distress threshold, indicating significant financial stress.

  • Below 1.8 — Distress Zone (high bankruptcy risk)
  • 1.8 to 3.0 — Gray Zone (elevated uncertainty)
  • Above 3.0 — Safe Zone (financially healthy)

What drives CPB's Z-Score?

Altman Z-Score components for CPB
ComponentFormulaValueWeightContribution
A · Working Capital / Total AssetsWC / TA-0.04521.2-0.05
B · Retained Earnings / Total AssetsRE / TA0.31511.40.44
C · EBIT / Total AssetsEBIT / TA0.07663.30.25
D · Market Cap / Total LiabilitiesMCap / TL0.56470.60.34
E · Revenue / Total AssetsRev / TA0.68831.00.69

How has CPB's financial health changed over time?

3.0 Safe1.8 Distress0.01.02.03.04.02022202320242025
CPB Z-Score history
YearZ-ScoreZone
20221.86Gray
20232.08Gray
20241.49Distress
20251.67Distress

Source: Calculated from CPB's latest 10-K filing on SEC EDGAR.

Section 02 · Fair Value Estimate

What is The Campbell's Company actually worth?

FVL Fair Value$20.83
vs
Market Price$20.82
Watch Zone 0.1% Stock trades 0.1% below our estimated fair value of $20.83.

How we calculated this

FVL Valuation Model
InputValueSource
Predicted EPS (α)$2.17Proprietary blend of reported actuals (2Q actual) + analyst consensus, weighted by α
Last Year EPS$2.01Annual report (SEC EDGAR)
Analyst Consensus EPS (This Year)$2.1917 analysts consensus
Trailing P/E11.3xCurrent market pricing
Fair P/E (β discount)9.6xTrailing PE adjusted by value discount factor β, hard-capped
Earnings Trend (γ)AcceleratingDirectional signal: predicted vs trailing EPS

Wall Street Reference: Analyst consensus target price is $24.18 (17 analysts). This is shown for reference only and is not used in our valuation model.

Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.

Section 03 · Competitive Moat

Does The Campbell's Company have a durable competitive advantage?

★★★☆☆
Narrow moat

Moat rating: 3.4/5.

What makes up CPB's moat score?

ROIC Stability

★★★★☆

ROIC variability over the past decade. Score: 4/5.

Gross Margin Trend

★★★☆☆

Gross margin trajectory over the past decade. Score: 3/5.

Switching Costs

★★★☆☆

Estimated customer lock-in based on margin level. Score: 3/5.

How stable is CPB's return on invested capital?

0%-5%1%8%14%21%2022202320242025
CPB ROIC history
YearROICTrend
202214.3%
202315.8%Rising
20249.2%Declining
202510.7%Rising

Source: ROIC calculated from SEC EDGAR filings.

Section 04 · Dividend Safety

Is The Campbell's Company's dividend safe?

B Dividend Safety Grade
Yield7.5%
Payout Ratio84.8%
Consecutive Years43
5Y Growth Rate-12.0%

Can The Campbell's Company afford its dividend?

Payout ratio is 84.8%. FCF covers the dividend 2.1x. 43 consecutive years of payments.

Section 05 · Financial Summary

The Campbell's Company's key financial metrics

CPB financial summary
MetricLatest1Y Ago3Y AgoTrend
Revenue $10.3B $9.6B $8.6B Rising
Net Income $0.6B $0.6B $0.8B Declining
Free Cash Flow $0.7B $0.7B $0.9B Declining
Gross Margin 30.4% 30.8% 30.7% Stable
Section 06 · Lab Signals

Recent events that affect our CPB analysis

EARNINGS

CPB earnings report scheduled

Lab Impact

Upcoming report. Consensus EPS estimate: $0.49. Revenue estimate: $2.39B. Our current Fair Value: $20.83 — a significant beat or miss could shift this estimate.

ANALYST

CPB analyst consensus: 16% bullish (3 of 19 analysts)

Lab Impact

0 Strong Buy, 3 Buy, 11 Hold, 2 Sell, 3 Strong Sell. Consensus target: $24.18 (16.1% upside). Compare with our independent Fair Value: $20.83.

DIVIDEND

CPB paid $0.3900/share dividend

Lab Impact

Dividend Safety Grade: B. Payout ratio: 84.8%.

EARNINGS

CPB missed EPS estimates by 10.6%

Lab Impact

Reported EPS: $0.51 vs estimate $0.57. Our Fair Value of $20.83 may face downward pressure if the trend continues.

FILING

CPB filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

CPB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

CPB paid $0.3900/share dividend

Lab Impact

Dividend Safety Grade: B. Payout ratio: 84.8%.

FILING

CPB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

CPB beat EPS estimates by 5.0%

Lab Impact

Reported EPS: $0.77 vs estimate $0.73. Earnings strength supports our Fair Value of $20.83 (0.0% above current price).

FILING

CPB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CPB filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

CPB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CPB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CPB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CPB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

CPB paid $0.3900/share dividend

Lab Impact

Dividend Safety Grade: B. Payout ratio: 84.8%.

FILING

CPB filed annual report (10-K)

Lab Impact

Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →

FILING

CPB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

CPB beat EPS estimates by 9.0%

Lab Impact

Reported EPS: $0.62 vs estimate $0.57. Earnings strength supports our Fair Value of $20.83 (0.0% above current price).

FILING

CPB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CPB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CPB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

CPB paid $0.3900/share dividend

Lab Impact

Dividend Safety Grade: B. Payout ratio: 84.8%.

EARNINGS

CPB beat EPS estimates by 11.4%

Lab Impact

Reported EPS: $0.73 vs estimate $0.66. Earnings strength supports our Fair Value of $20.83 (0.0% above current price).

FILING

CPB filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

CPB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

CPB paid $0.3900/share dividend

Lab Impact

Dividend Safety Grade: B. Payout ratio: 84.8%.

EARNINGS

CPB beat EPS estimates by 2.3%

Lab Impact

Reported EPS: $0.74 vs estimate $0.72. Earnings strength supports our Fair Value of $20.83 (0.0% above current price).

FILING

CPB filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

CPB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

CPB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

CPB paid $0.3900/share dividend

Lab Impact

Dividend Safety Grade: B. Payout ratio: 84.8%.

Section 07 · FAQ

Common questions about The Campbell's Company

What is The Campbell's Company stock price today?

The Campbell's Company (CPB) stock price is $20.82 as of the latest market close, traded on the NASDAQ exchange.

What does The Campbell's Company do?

The Campbell's Company, together with its subsidiaries, manufactures and markets food and beverage products in the United States and internationally. It operates through Meals & Beverages, and Snacks segments. The Meals & Beverages segment engages in the retail and foodservice businesses in the United States and Canada.

What is The Campbell's Company market cap?

The Campbell's Company has a market capitalization of $6.21B, classifying it as a mid-cap stock in the Consumer Defensive sector.

What sector and industry is CPB in?

The Campbell's Company operates in the Consumer Defensive sector, specifically within the Packaged Foods industry. It trades on the NASDAQ under the ticker symbol CPB.

Is CPB stock overvalued or undervalued?

Based on our valuation model, The Campbell's Company trades 0.1% below our fair value estimate — potentially undervalued.

  • FairValueLabs Fair Value: $20.83
  • Current Price: $20.82
  • Valuation Zone: Watch Zone
What is CPB stock forecast and analyst target price?

Based on 17 Wall Street analysts, the consensus price target for The Campbell's Company is $24.18, implying upside of 16.1% from the current price.

  • Analyst High Target: $56.00
  • Analyst Low Target: $18.00

Note: Analyst targets are shown for reference and are not used in our valuation model.

Is The Campbell's Company revenue and earnings growing?

Here are the analyst consensus growth estimates for The Campbell's Company:

  • Revenue growth (current year est.): -4.2%
  • EPS growth (current year est.): -26.4%
  • Revenue growth (next year est.): 0.1%
  • EPS growth (next year est.): 1.2%
What are The Campbell's Company's key financial metrics?
MetricLatestTrend
Revenue$10.3BRising
Net Income$0.6BDeclining
Free Cash Flow$0.7BDeclining
Gross Margin30.4%Stable
What is CPB's P/E ratio?

The price-to-earnings ratio measures how much investors pay per dollar of earnings:

  • Trailing P/E (last 12 months): 11.3x
  • Forward P/E (next 12 months est.): 9.4x
  • FairValueLabs Fair P/E: 9.6x
How volatile is CPB stock?

The Campbell's Company has a beta of 0.03, meaning it is less volatile than the broader market. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.

How much cash and debt does The Campbell's Company have?

The Campbell's Company's balance sheet shows:

  • Total Cash: $561.0M
  • Total Debt: $7.41B
  • Net Cash Position: $-6.85B

A positive net cash position means the company holds more cash than debt, reducing financial risk.

What is The Campbell's Company's free cash flow?

The Campbell's Company generated $862.5M in trailing twelve-month free cash flow (from $1.13B in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.

Does The Campbell's Company pay a dividend, and is it safe?

Yes, The Campbell's Company pays a regular dividend. Here are the key metrics:

  • Dividend Yield: 7.5%
  • Payout Ratio: 84.8%
  • Consecutive Years Paid: 43
  • 5-Year Dividend Growth: -12.0%
  • FairValueLabs Safety Grade: B
Is The Campbell's Company at risk of going bankrupt?

The Campbell's Company's Altman Z-Score is 1.67, placing it in the distress zone (below 1.8) — elevated bankruptcy risk. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.

Does The Campbell's Company have a durable competitive advantage?

The Campbell's Company scores 3.4/5 stars (Narrow moat) in our moat analysis:

  • ROIC Stability: 4/5
  • Gross Margin Trend: 3/5
  • Switching Costs: 3/5

A score above 3.5 suggests meaningful pricing power and a defensible market position.

What is CPB's return on equity (ROE)?

The Campbell's Company's return on equity is 13.9%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.

How do I buy CPB stock?

CPB shares can be purchased through any brokerage account that provides access to the NASDAQ. Common steps:

  1. Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
  2. Search for ticker symbol CPB
  3. Place a market or limit order for your desired number of shares

This is not investment advice. Always do your own research before buying any stock.

Is CPB a value stock or speculative?

FairValueLabs classifies The Campbell's Company as Value Investment. It exhibits consistent profitability, reasonable valuation, and financial stability — characteristics of a traditional value investment.

Who is the CEO of The Campbell's Company?

The current CEO of The Campbell's Company is Mr. Mick J. Beekhuizen.

What is CPB's earnings per share (EPS)?

Earnings per share measures the company's profit allocated to each outstanding share:

  • Trailing EPS (last 12 months): $1.84
  • Forward EPS (next 12 months est.): $2.22
  • Analyst consensus EPS (this year): $2.19
  • Analyst consensus EPS (next year): $2.21

FairValueLabs Disclaimer

All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.

This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.

Last updated: Apr 22, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.

CPB analysis methodology: How we calculate fair value, Z-Scores, and moat ratings